Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Simbolo

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Familial Cancer|January 25, 2022
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variantsAndrea Mafficini, Lodewijk A A Brosens, Maria L Piredda, et al.
Histopathology|January 31, 2023
Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoidsGiovanni Centonze, Patrick Maisonneuve, Michele Simbolo, et al.
Cancer Immunology Research|November 8, 2018
Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell SecretomeRaffaella Vescovi, Matilde Monti, Daniele Moratto, et al.
The Journal of Pathology|November 23, 2016
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2DMichele Simbolo, Andrea Mafficini, Katarzyna O Sikora, et al.
Therapeutic Advances in Medical Oncology|November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevanceSara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.
Breast (Edinburgh, Scotland)|February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological modelLuisa Carbognin, Michele Simbolo, Anna Caliò, et al.
Cancers|August 23, 2020
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot StudyGiuseppe Lombardi, Valeria Barresi, Stefano Indraccolo, et al.
The Journal of Pathology. Clinical Research|March 6, 2025
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behaviorGiovanna Sabella, Giovanni Centonze, Patrick Maisonneuve, et al.
Oncotarget|May 29, 2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroupsMichele Simbolo, Matteo Fassan, Andrea Ruzzenente, et al.
Human Pathology|July 19, 2022
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreasAnastasios Gkountakos, Andrea Mafficini, Emil Lou, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Familial Cancer|January 25, 2022
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variantsAndrea Mafficini, Lodewijk A A Brosens, Maria L Piredda, et al.
Histopathology|January 31, 2023
Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoidsGiovanni Centonze, Patrick Maisonneuve, Michele Simbolo, et al.
Cancer Immunology Research|November 8, 2018
Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell SecretomeRaffaella Vescovi, Matilde Monti, Daniele Moratto, et al.
The Journal of Pathology|November 23, 2016
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2DMichele Simbolo, Andrea Mafficini, Katarzyna O Sikora, et al.
Therapeutic Advances in Medical Oncology|November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevanceSara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.
Breast (Edinburgh, Scotland)|February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological modelLuisa Carbognin, Michele Simbolo, Anna Caliò, et al.
Cancers|August 23, 2020
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot StudyGiuseppe Lombardi, Valeria Barresi, Stefano Indraccolo, et al.
The Journal of Pathology. Clinical Research|March 6, 2025
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behaviorGiovanna Sabella, Giovanni Centonze, Patrick Maisonneuve, et al.
Oncotarget|May 29, 2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroupsMichele Simbolo, Matteo Fassan, Andrea Ruzzenente, et al.
Human Pathology|July 19, 2022
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreasAnastasios Gkountakos, Andrea Mafficini, Emil Lou, et al.
Pageof 9